APR 22, 2016 2:17 PM PDT

World's First Blood Test for Parkinson's Disease

WRITTEN BY: Xuan Pham
Parkinson’s disease affects nearly 10 million people worldwide, yet diagnosis of this devastating disease is often done through a process of elimination. But this somewhat crude method may get an unprecedented upgrade, as researchers from La Trobe University in Australia announced the first blood test for Parkinson’s disease. The study details are under review, but news of this diagnostic potential has helped raised $800,000 to accelerate the research so that the test may be available in the next five years.
First Parkinson's blood test may be arriving in 5 years
"This is a really exciting discovery. Parkinson's is a debilitating disorder and currently there is no cure. However, early diagnosis and treatment could enable better outcomes and a greater quality of life for people with the condition, which will be of great benefit to sufferers and their families,” said Paul Fisher, Professor of Microbiology at La Trobe University, Australia.
 
Parkinson’s disease is characterized by progressive neurodegeneration, causing severe impairments in movement. Most often, the disease is associated with uncontrolled tremors; however, patients can also suffer from muscle stiffness and the difficulty moving or speaking. Because the disease is progressive, symptoms worsen over time. There are no cures, but medications can improve some of the symptoms, especially if the disease is diagnosed at early stages.
 

Though causes of Parkinson’s disease are still undetermined, researchers are working through a number of likely suspects. In particular, Fisher’s team is focused on mitochondrial dysfunction. The mitochondria is the cell’s energy source, and it’s thought that overproduction of a toxic byproduct by this organelle contributes to neuronal breakdown.
 
“Based on the current literature we were expecting reduced oxygen consumption in the mitochondria, which leads to a build up of toxic byproducts, but what we saw was the exact opposite,” Fisher said. “We were able to show the mitochondria were perfectly normal but were working four times as hard, which also leads to increased production of poisonous byproducts to occur.”
 
Leveraging this discovery from ten years ago, Fisher and his team developed the blood test based on measuring the production of mitochondria by-products. The presence and abundance of the biomarker will allow the team to predict Parkinson’s disease, in advance of neurological symptoms that may not show up until years later.
 
In a small trial with 38 participants, including 29 with Parkinson’s disease, they reported the test had high reliability and accuracy. In the next phase, they will scale up the test in 100 people, including 70 with Parkinson’s.
 
With eyes on the first diagnostic blood test for Parkinson’s, the team is also hopeful that the method can be applied to other neurodegenerative diseases. “It is even possible that the blood test could be developed to detect all types of neuro-degenerative disorders, including Alzheimer's,” said Fisher. “We're hoping to both speed it up and scale it down so that we can use it on very small blood samples in the future,” he added.
 
It’s important to note that even if the disease is diagnosed earlier, current available treatments can’t slow the progression of Parkinson’s. Even still, patients will undoubtedly benefit from early diagnosis, as prompt treatment may help curb the worsening symptoms over time. 

Additional source: The Guardian
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
MAY 06, 2021
Clinical & Molecular DX
Sweat Sensor Can Tell If a Storm's Coming
MAY 06, 2021
Sweat Sensor Can Tell If a Storm's Coming
A surge of pro-inflammatory cytokines, intense, and sustained inflammation leading to organ damage and a high risk of de ...
MAY 04, 2021
Cardiology
Does Sleep Apnea Affect Blood Pressure During REM Sleep?
MAY 04, 2021
Does Sleep Apnea Affect Blood Pressure During REM Sleep?
Sleep is a time for your body to rest and recover from the day. Your heart slows down, and your breathing relaxes.   ...
MAY 11, 2021
Clinical & Molecular DX
Every Minute Counts: Opportunities for Faster Blood Culture Results
MAY 11, 2021
Every Minute Counts: Opportunities for Faster Blood Culture Results
Sepsis is one of the most significant challenges in critical care, and early diagnosis is a decisive factor in determini ...
MAY 10, 2021
Clinical & Molecular DX
Noninvasive Device Warns When Wounds Are Bleeding
MAY 10, 2021
Noninvasive Device Warns When Wounds Are Bleeding
Patients with kidney failure have to undergo hemodialysis—a process where a dialysis machine takes the place of ki ...
JUN 10, 2021
Clinical & Molecular DX
Algorithm Flags High Risk of Pancreatic Cancer
JUN 10, 2021
Algorithm Flags High Risk of Pancreatic Cancer
In 2021, over 60,000 individuals in the U.S. alone will be diagnosed with pancreatic cancer. Researchers are turning to ...
JUN 29, 2021
Immunology
Speed Up qPCR Sample Preparation for SARS-CoV-2 Detection
JUN 29, 2021
Speed Up qPCR Sample Preparation for SARS-CoV-2 Detection
Amid the widespread outbreak of the COVID-19 caused by SARS-CoV-2, the development of test methods that can efficiently ...
Loading Comments...